From the category archives:

FDA

Resources and Tools for Preventing Surgical Fires

by lowes1 on February 6, 2012

Healthy People Co. Dietary Supplements: Recall – Undeclared Drug Ingredient

by lowes1 on February 6, 2012

Gris-PEG (griseofulvin ultramicrosize): Health Advisory – Risk of Product Mix-Up

by lowes1 on February 3, 2012

Initiative Partners

by lowes1 on February 3, 2012

Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall – Visible Glass Particle

by lowes1 on February 3, 2012

Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall – Possibility of Inexact Tablet Counts or Out of Sequence Tablets

by lowes1 on February 1, 2012

Vitaflo USA Renastart: Recall – Possible Health Risk Due To Incorrectly Labeled Cans

by lowes1 on January 31, 2012

Treanda (bendamustine HCL): Recall – Particulate Matter in Vial

by lowes1 on January 30, 2012

Tysabri (natalizumab): Drug Safety Communication – New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)

by lowes1 on January 20, 2012

FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)

by lowes1 on January 20, 2012

← Previous Entries